Displaying 73 - 84 of 84
Viral Hepatitis
5

Gilead Sciences: The Next Chapter in Viral Hepatitis - ILC 2021

View
Viral Hepatitis
5

Gilead Sciences: The Next Chapter in Viral Hepatitis - ILC 2021

View
Viral Hepatitis
5

Gilead Sciences: The Next Chapter in Viral Hepatitis - ILC 2021

View
Liver Tumours
6

Boston Scientific: SIRT: The versatility of current HCC treatment & the opportunities for the future - Digital Liver Cancer Summit 2021

View
Liver Tumours
6

Boston Scientific: SIRT: The versatility of current HCC treatment & the opportunities for the future - Digital Liver Cancer Summit 2021

View
Liver Tumours
6

Boston Scientific: SIRT: The versatility of current HCC treatment & the opportunities for the future - Digital Liver Cancer Summit 2021

View
Liver Tumours
6

Boston Scientific: SIRT: The versatility of current HCC treatment & the opportunities for the future - Digital Liver Cancer Summit 2021

View
Liver Tumours
6

Boston Scientific: SIRT: The versatility of current HCC treatment & the opportunities for the future - Digital Liver Cancer Summit 2021

View
Liver Tumours
6

Boston Scientific: SIRT: The versatility of current HCC treatment & the opportunities for the future - Digital Liver Cancer Summit 2021

View
Immune-Mediated and Cholestatic Diseases
3

Albireo: New Developments in the Management of Progressive Familial Intrahepatic Cholestasis (PFIC) - ILC 2021

View
Immune-Mediated and Cholestatic Diseases
3

Albireo: New Developments in the Management of Progressive Familial Intrahepatic Cholestasis (PFIC) - ILC 2021

View
Immune-Mediated and Cholestatic Diseases
3

Albireo: New Developments in the Management of Progressive Familial Intrahepatic Cholestasis (PFIC) - ILC 2021

View
Displaying 73 - 84 of 84